Table 4. Correlation analysis at each time-point among functional and morphological parameters.
| Baseline | 1 Month | 2 Months | 3 Months | 4 Months | 5 Months | 6 Months | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n = 27 | n = 27 | n = 27 | n = 27 | n = 27 | n = 21 | n = 12 | ||||||||||||||||
| CMT | MP1 | BCVA | CMT | MP1 | BCVA | CMT | MP1 | BCVA | CMT | MP1 | BCVA | CMT | MP1 | BCVA | CMT | MP1 | BCVA | CMT | MP1 | BCVA | ||
| BCVA | ρ | 0.701 | -0.646 | - | 0.481 | -0.789 | - | 0.197 | -0.768 | - | 0.323 | -0.421 | - | 0.359 | -0.294 | - | 0.327 | -0.616 | - | 0.958 | -0.988 | - |
| p | <0.0001 | <0.0001 | - | 0.011 | <0.0001 | - | 0.324 | <0.0001 | - | 0.178 | 0.033 | - | 0.125 | 0.137 | - | 0.147 | 0.003 | - | <0.0001 | <0.0001 | - | |
| MP1 | ρ | -0.447 | - | -0.646 | -0.254 | - | -0.789 | -0.497 | - | -0.768 | -0.334 | - | -0.421 | 0.246 | - | -0.294 | -0.320 | - | -0.616 | -0.923 | - | -0.988 |
| p | 0.019 | - | <0.0001 | 0.2 | - | <0.0001 | 0.008 | - | <0.0001 | 0.074 | - | 0.033 | 0.217 | - | 0.137 | 0.157 | - | 0.003 | <0.0001 | - | <0.0001 | |
| CMTT | ρ | - | -0.447 | 0.701 | - | -0.254 | 0.481 | - | -0.497 | 0.197 | - | -0.334 | 0.323 | - | 0.246 | 0.359 | - | -0.320 | 0.327 | - | -0.923 | 0.958 |
| p | - | 0.019 | <0.0001 | - | 0.2 | 0.011 | - | 0.008 | 0.324 | - | 0.074 | 0.178 | - | 0.217 | 0.125 | - | 0.157 | 0.147 | - | <0.0001 | <0.0001 | |
BCVA: best-corrected visual acuity; MP1: microperimetry; CMT: central macular thickness; n: number of patients. Non-parametric correlation analysis (Spearman test) was conducted in order to obtain p-values.